LUNG

NASDAQ 已收盘

Pulmonx

2.57 USD
▼-0.17-6.20%
盘后 2.65 +3.11%
2026-11-20
市值
$111.93M
市盈率
—
EPS
-1.01
股息率
—
52 周区间
1.13 – 3.25
成交量
934.27K
Beta
0.17
目标价
4.25
52W 低 1.1352W 高 3.25
价格走势

公司简介

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with mult...